Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-02-10

Clinical Trial Update: Hormonal Contraceptive Use and the Risk of Provoked Vestibulodynia

View source ↗

Summary

A clinical trial evaluating the relationship between hormonal contraceptive use and the risk of provoked vestibulodynia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hormonal contraceptives

Snippet

Sponsor: ahinoam lev sagie | Conditions: Vestibulodynia | Status: WITHDRAWN